Friday, March 6, 2020
NIAID Now: Superior AIDS-Kaposi’s Sarcoma Treatment Improves Outcomes in Resource-Limited Settings
The cancer drug paclitaxel and a suppressive regimen of antiretroviral therapy (ART) is an effective treatment for AIDS-related Kaposi’s sarcoma, according to researchers who conducted a clinical trial comparing three chemotherapy regimens in combination with ART in people with advanced AIDS-Kaposi’s sarcoma in Africa and South America. The full findings, published online yesterday in The Lancet, affirmed conclusions from interim data released when the trial ended early in March 2018.
No comments:
Post a Comment